Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Liabilities and Shareholders Equity (2020 - 2026)

NeuroPace has reported Liabilities and Shareholders Equity over the past 7 years, most recently at $98.9 million for Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity fell 10.26% year-over-year to $98.9 million; the TTM value through Mar 2026 reached $417.8 million, up 5.63%, while the annual FY2025 figure was $105.6 million, 11.54% up from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 was $98.9 million at NeuroPace, down from $105.6 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $129.0 million in Q1 2022 and troughed at $94.4 million in Q2 2024.
  • A 5-year average of $106.5 million and a median of $106.1 million in 2025 define the central range for Liabilities and Shareholders Equity.
  • On a YoY basis, Liabilities and Shareholders Equity climbed as much as 156.3% in 2022 and fell as far as 19.34% in 2022.
  • Year by year, Liabilities and Shareholders Equity stood at $114.1 million in 2022, then decreased by 5.66% to $107.7 million in 2023, then decreased by 12.08% to $94.6 million in 2024, then grew by 11.54% to $105.6 million in 2025, then dropped by 6.32% to $98.9 million in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for NPCE at $98.9 million in Q1 2026, $105.6 million in Q4 2025, and $107.3 million in Q3 2025.